ClinicalTrials.govpublic full text
To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL
b-cell acute lymphoblastic leukemia, cd19, car-t, relapsed /refractory, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 824946
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.